How Would You Treat This Patient With Acute and Chronic Pain From Sickle Cell Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center

Ann Intern Med. 2022 Apr;175(4):566-573. doi: 10.7326/M22-0038. Epub 2022 Apr 12.

Abstract

Sickle cell disease is prevalent in large numbers of patients in the United States and has a significant global impact. Its complications span numerous organs and lead to reduced life expectancy. Acute and chronic sickle cell pain is a common cause of patient suffering. The American Society of Hematology published updated guidelines on management of acute and chronic pain from sickle cell disease in 2019. Several of the recommendations are conditional and leave specific decisions to the treating physician. These include conditional recommendations about the use of ketamine for acute pain and the initiation and discontinuation of long-term opioid therapy for chronic pain. Here, 2 hematologists discuss these guidelines and make contrasting recommendations for the management of acute and chronic pain for a patient with sickle cell disease.

Publication types

  • Clinical Conference

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Anemia, Sickle Cell* / complications
  • Chronic Pain* / drug therapy
  • Chronic Pain* / etiology
  • Humans
  • Practice Guidelines as Topic
  • Teaching Rounds*
  • United States

Substances

  • Analgesics, Opioid